The Canadian COVID‑19 Funded Research Database

Algonquin College
Ambrose University
Association for Canadian Studies
Athabasca University
Aurora College

B.C. Centre for Disease Control
B.C. Centre for Excellence in HIV/AIDS
B.C. Children's Hospital
B.C. Women's Hospital
Bishop's University
Brandon University
British Columbia Centre on Substance Use
Brock University
Bruyère Research Institute

Dalhousie University
Dawson College
Durham College

École de technologie supérieure
École nationale d'administration publique
École Polytechnique de Montréal
Emily Carr University of Art and Design

Fanshawe College
First Nations Health Authority
Fleming College

Georgian College
Grant MacEwan University

HEC Montréal
Hospital for Sick Children
Humber College
Huron University College

Indigenous Diabetes Health Circle
INRS
Institut de recherches cliniques de Montréal
Institut de tourisme et d'hôtellerie du Québec
Institut national de la recherche scientifique
Institut national de santé publique du Québec
Institute for Work & Health
IWK Health Centre

John Abbott College
Justice Institute of British Columbia

Keenan Research Centre
King's University College at Western University
Kwantlen Polytechnic University

MacEwan University (Grant MacEwan University)
McGill University
McMaster University
Memorial University of Newfoundland
Métis Nation of Ontario
Mount Royal University
Mount Saint Vincent University
Moyo Health and Community Services

Native Women's Association of Canada
North Island College
North York General Hospital
Northern Ontario School of Medicine
Nova Scotia Health Authority

OCAD University
Ontario Centre of Excellence for Child and Youth Mental Health
Ontario Institute for Cancer Research
Ontario Tech University
Ontario Tech University (University of Ontario Institute of Technology)
Ottawa Heart Institute Research Corporation
Ottawa Hospital Research Institute

Princess Margaret Cancer Centre

Québec à Chicoutimi
Québec à Montréal
Québec à Rimouski
Québec à Trois-Rivières
Queen's University

Royal Alexandra Hospital
Royal Roads University
Ryerson University

TÉLUQ
The University of Calgary
The University of Regina
Thompson Rivers University
Toronto General Research Institute
Trent University
Trillium Health Partners

Vancouver Island University

Western University
Western University (The University of Western Ontario)
Wilfrid Laurier University
Women's College Hospital

York University
Yukon University

Back to main page

Displaying 231 through 240 of 353 results (Download Results)

Show results per page

Health equity and the post COVID‑19 condition

Kendall, Claire | Bruyère Research Institute | Operating Grant | $221,728

CIHR Ontario 2021

An intervention to teach self-management skills for persisting symptoms of COVID-19: Minimizing impact of symptoms on everyday functioning and on healthcare usage/utilization – A randomized controlled trial

Green, Robin E | University Health Network | Operating Grant | $330,562

CIHR Ontario 2021

Investigating the Post-Acute Sequelae of SARS-CoV-2 Infections: a Patient Oriented Canadian COVID‑19 Emergency Department Rapid Response Network (CCEDRRN) Study

Archambault, Patrick | Université Laval | Operating Grant | $499,945

CIHR Quebec 2021

COVID-19 Variant Supplement – Predicting the risk of developing mental and substance use disorders due to COVID-19: machine learning applied to health service utilization data to facilitate access to effective treatments.

Vigo, Daniel V | University of British Columbia | Operating Grant | $50,000

CIHR British Columbia 2021

SARS-CoV-2 triggers Autoimmunity: implications for the pathogenesis of Post-Acute COVID‑19 Syndrome – (AI-PACS)

Mukherjee, Manali | McMaster University | Operating Grant | $499,245

CIHR Ontario 2021

Pregnant and Lactating Individuals & Newborns COVID‑19 Vaccination Study

El-Chaar, Darine | Ottawa Hospital Research Institute | Operating Grant | $500,000

CIHR Ontario 2021

COVID-19 Variant Supplement – RIsk of environmental Surface and air Contamination in COVID19 (RISC-COV)

McGeer, Allison J | Sinai Health System | Operating Grant | $49,928

CIHR Ontario 2021

Errant epitopes from arginine methylated SARS-CoV-2 proteins predisposing to autoimmune diseases.

Richard, Stéphane | Lady Davis Institute for Medical Research | Operating Grant | $309,250

CIHR Quebec 2021

Immune response after COVID‑19 vaccination during maintenance therapy in immune-mediated inflammatory diseases: an observational cohort study (IMPACT)

Chandran, Vinod | University Health Network | Operating Grant | $499,800

CIHR Ontario 2021

COVID-19 Variant Supplement – Bespoke transition state analog inhibitors of SARS-CoV-2 3CL and PL proteases

Strynadka, Natalie C | University of British Columbia | Operating Grant | $50,000

CIHR British Columbia 2021

The Canadian COVID‑19 Funded Research Database

Advanced Keyword Search

Provinces & Territories (12)

Institutions (175)

A

B

C

D

E

F

G

H

I

J

K

L

M

N

O

P

Q

R

S

T

U

V

W

Y

Years (4)

Funding Agencies (3)

Languages (2)

Funding Amount

Health equity and the post COVID‑19 condition

An intervention to teach self-management skills for persisting symptoms of COVID-19: Minimizing impact of symptoms on everyday functioning and on healthcare usage/utilization – A randomized controlled trial

Investigating the Post-Acute Sequelae of SARS-CoV-2 Infections: a Patient Oriented Canadian COVID‑19 Emergency Department Rapid Response Network (CCEDRRN) Study

COVID-19 Variant Supplement – Predicting the risk of developing mental and substance use disorders due to COVID-19: machine learning applied to health service utilization data to facilitate access to effective treatments.

SARS-CoV-2 triggers Autoimmunity: implications for the pathogenesis of Post-Acute COVID‑19 Syndrome – (AI-PACS)

Pregnant and Lactating Individuals & Newborns COVID‑19 Vaccination Study

COVID-19 Variant Supplement – RIsk of environmental Surface and air Contamination in COVID19 (RISC-COV)

Errant epitopes from arginine methylated SARS-CoV-2 proteins predisposing to autoimmune diseases.

Immune response after COVID‑19 vaccination during maintenance therapy in immune-mediated inflammatory diseases: an observational cohort study (IMPACT)

COVID-19 Variant Supplement – Bespoke transition state analog inhibitors of SARS-CoV-2 3CL and PL proteases